Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$240,494,721
+$85,270,706 QoQ
Shares Held
1,804,703
+29.5% QoQ
Ownership
2.07%
of shares outstanding
% of Portfolio
11.64%
of 13F equity value
Holder Rank
#7
of 302 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Derivatives in ABVX
reported options exposure · as of Jun 30, 2026CallValue
$5,916,744
CallShares
44,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. ABVX ranks #1 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
This page
|
1,804,703 | $240,494,721 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
960,863 | $117,782,586 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,157,008 | $111,726,513 | |
| 4 | IMVT |
Immunovant, Inc.
|
2,330,716 | $89,802,487 | |
| 5 | ZLAB |
Zai Lab Ltd
|
3,369,034 | $64,011,646 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,288,053 | $47,799,646 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,222,080 | $45,730,233 | |
| 8 | CYTK |
Cytokinetics Inc
|
457,907 | $39,009,097 |
All Filings in ABVX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $240,494,721 | 1,804,703 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $5,916,744 | 44,400 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $155,224,015 | 1,394,019 | Shares | Sole | 2026-05-18 | |
| 2026-03-31 | $4,899,400 | 44,000 | Call | Sole | 2026-05-18 | |
| 2025-12-31 | $177,648,402 | 1,317,329 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $114,685,127 | 1,350,826 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $23,495,751 | 3,071,340 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,812,618 | 2,210,019 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,078,036 | 1,513,393 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,008,970 | 521,612 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $356,940 | 27,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $214,500 | 15,000 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||